Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma with high mutation burdens but a low response rate to immune checkpoint inhibitors. In this study, we performed targeted next-generation sequencing and fluorescent multiplex immunohistochemistry, and investigated the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Hua, Xu-Monette, Zijun Y., Wei, Li, Nunns, Harry, Nagy, Máté L., Bhagat, Govind, Fang, Xiaosheng, Zhu, Feng, Visco, Carlo, Tzankov, Alexandar, Dybkaer, Karen, Chiu, April, Tam, Wayne, Zu, Youli, Hsi, Eric D., Hagemeister, Fredrick B., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Benjamin M., Van Krieken, J. Han, Piris, Miguel A., Winter, Jane N., Li, Yong, Au, Qingyan, Xu, Bing, Albitar, Maher, Young, Ken H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293967/
https://www.ncbi.nlm.nih.gov/pubmed/34350060
http://dx.doi.org/10.1080/2162402X.2021.1928365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293967/
https://www.ncbi.nlm.nih.gov/pubmed/34350060
http://dx.doi.org/10.1080/2162402X.2021.1928365

Ejemplares similares